IVOG Fees and Costs — Vanguard S&P Mid-Cap 400 Growth Index Fund
Data updated: 2026-07-29
The net expense ratio is 0.10%: a 0.08% management fee plus 0.02% other expenses. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $31K in broker commissions, 0.0025% of average net assets, and portfolio turnover was 38%.
IVOG Fees and Expenses
Annual operating expenses and sales charges of IVOG. Prospectus, as of August 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.08% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.02% |
| Gross expense ratio | 0.10% |
| Fee waiver | — |
| Net expense ratio | 0.10% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
IVOG Costs Over Time
On $10,000 invested in IVOG, assuming 5% a year before costs, total costs come to $65 over 5 years, cutting the return by 0.11% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.10%) | $10 | $33 | $58 |
| Trading costs (broker commissions) | $0 | $1 | $1 |
| Lost growth on money paid in costs | $0 | $2 | $6 |
| Total costs | $11 | $36 | $65 |
| Value after costs | $10,489 | $11,541 | $12,698 |
| Impact on return, per year | 0.11% | 0.11% | 0.11% |
IVOG Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0025%
- Total broker commissions: $31K
- Bought from dealers (principal trades, not a cost): $76.3M
- Portfolio turnover (prospectus): 38%
- Securities on loan, average value: $903K
- Net income from securities lending: $24K (0.002% of average net assets)
IVOG Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BARCLAYS PLC | $9K | 31.61% |
| MORGAN STANLEY | $7K | 21.96% |
| JPMORGAN CHASE & CO. | $5K | 15.80% |
| CITIGROUP INC. | $3K | 9.46% |
| WELLS FARGO & COMPANY | $2K | 6.40% |
| BANK OF AMERICA CORPORATION | $2K | 5.60% |
| CITADEL SECURITIES LP | $847 | 2.83% |
| VIRTU FINANCIAL, INC. | $700 | 2.34% |
| THE GOLDMAN SACHS GROUP, INC. | $605 | 2.02% |
| Mizuho Financial Group, Inc. | $594 | 1.98% |
IVOG Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Vanguard Market Liquidity Fund | $75.4M | 98.76% |
| JPMORGAN CHASE & CO. | $580K | 0.76% |
| CITIGROUP INC. | $204K | 0.27% |
| WELLS FARGO & COMPANY | $160K | 0.21% |
Vanguard S&P Mid-Cap 400 Growth Index Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| VMFGX | Institutional Shares | 0.03% | none |
| IVOG | ETF Shares | 0.10% | — |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.